Sonoma Pharmaceuticals Reported Earnings

Sonoma Pharmaceuticals (SNOA) reported earnings of $0.02 per share on revenue of $6.41 million for the . . Revenue grew 59.55% on a year-over-year basis.

Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus Innovative Sciences and is headquatered in Petaluma, California.